Receptor tyrosine-protein kinase erbB-2 inhibitor therapy

Receptor tyrosine-protein kinase erbB-2 inhibitor therapy (procedure)

procedure
£1.00

Supplier: international · SCTID 1237262009

Also known as (3)
  • HER2 (Human epidermal growth factor receptor 2) inhibitor therapy
  • Human epidermal growth factor receptor 2 inhibitor therapy
  • Human epidermal growth factor receptor 2 targeted therapy

Found in

Drug therapy

Related products

Acitretin therapy
£1.00
Adalimumab therapy
£1.00
Adjuvant drug therapy
£1.00
Administration of low dose ketamine
£1.00
Administration of prophylactic drug or medicament
£1.00
Administration of radiosensitising drug
£1.00
Administration of steroid
£1.00
Advance supply of antibiotic medication
£1.00
Advance supply of controlled medication
£1.00
Advance supply of steroid medication
£1.00
Ambrisentan therapy
£1.00
Amiodarone therapy
£1.00
Anastrozole therapy
£1.00
Angiotensin converting enzyme inhibitor therapy
£1.00
Angiotensin II receptor antagonist therapy
£1.00
Anifrolumab therapy
£1.00
Antacid therapy
£1.00
Anthraquinone therapy
£1.00
Anti-dementia drug therapy
£1.00
Anti-obesity drug therapy
£1.00
Anti-oestrogen therapy
£1.00
Antibiotic therapy
£1.00
Anticoagulant therapy
£1.00
Anticonvulsant therapy
£1.00
Basket
Total£0.00